Extended N-Sulfated Domains Reside at the Nonreducing End of Heparan Sulfate Chains*
暂无分享,去创建一个
[1] R. Reed,et al. Mutation in the Heparan Sulfate Biosynthesis Enzyme EXT1 Influences Growth Factor Signaling and Fibroblast Interactions with the Extracellular Matrix* , 2009, The Journal of Biological Chemistry.
[2] Robert J. Linhardt,et al. Analysis of Mutations in Fibroblast Growth Factor (FGF) and a Pathogenic Mutation in FGF Receptor (FGFR) Provides Direct Evidence for the Symmetric Two-End Model for FGFR Dimerization , 2005, Molecular and Cellular Biology.
[3] C. Bertozzi,et al. Compositional profiling of heparin/heparan sulfate using mass spectrometry: assay for specificity of a novel extracellular human endosulfatase. , 2005, Glycobiology.
[4] U. Lindahl,et al. Domain Structure of Heparan Sulfates from Bovine Organs* , 1996, The Journal of Biological Chemistry.
[5] J. Turnbull,et al. Heparan sulfate: decoding a dynamic multifunctional cell regulator. , 2001, Trends in cell biology.
[6] J. Schlessinger,et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.
[7] J. Turnbull,et al. Molecular organization of the interferon gamma-binding domain in heparan sulphate. , 1995, The Biochemical journal.
[8] Catherine E Costello,et al. Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform. , 2006, Biochemistry.
[9] H. Kitagawa,et al. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] M. Salmivirta,et al. Binding of Heparin/Heparan Sulfate to Fibroblast Growth Factor Receptor 4* , 2001, The Journal of Biological Chemistry.
[11] D. Ron,et al. Differential Effects of Heparin Saccharides on the Formation of Specific Fibroblast Growth Factor (FGF) and FGF Receptor Complexes* , 2002, The Journal of Biological Chemistry.
[12] P. Labosky,et al. SULF1 and SULF2 regulate heparan sulfate-mediated GDNF signaling for esophageal innervation , 2007, Development.
[13] Zhengliang L. Wu,et al. Characterizing the Non-reducing End Structure of Heparan Sulfate* , 2005, Journal of Biological Chemistry.
[14] J. Xie,et al. Isolation and characterization of heparan sulfate from various murine tissues , 2006, Glycoconjugate Journal.
[15] Roger Lawrence,et al. Disaccharide structure code for the easy representation of constituent oligosaccharides from glycosaminoglycans , 2008, Nature Methods.
[16] Jeffrey D. Esko,et al. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor , 1991, Cell.
[17] Catherine E Costello,et al. A chip‐based amide‐HILIC LC/MS platform for glycosaminoglycan glycomics profiling , 2009, Proteomics.
[18] S. Selleck,et al. Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.
[19] J. Spring,et al. Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. , 1992, Annual review of cell biology.
[20] David F. Burke,et al. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin , 2000, Nature.
[21] A. Petersen,et al. Heparan Sulfate-modulated, Metalloprotease-mediated Sonic Hedgehog Release from Producing Cells* , 2009, Journal of Biological Chemistry.
[22] D. Spillmann,et al. Heparin/Heparan Sulfate Biosynthesis , 2008, Journal of Biological Chemistry.
[23] M. Lyon,et al. A New Model for the Domain Structure of Heparan Sulfate Based on the Novel Specificity of K5 Lyase* , 2004, Journal of Biological Chemistry.
[24] G. David,et al. Membrane Heparan Sulfate Proteoglycan-supported FGF2-FGFR1 Signaling , 2001, The Journal of Biological Chemistry.
[25] T. Blundell,et al. Towards a resolution of the stoichiometry of the fibroblast growth factor (FGF)-FGF receptor-heparin complex. , 2004, Journal of molecular biology.
[26] A. Ori,et al. The heparanome and regulation of cell function: structures, functions and challenges. , 2008, Frontiers in bioscience : a journal and virtual library.
[27] R. Midura,et al. Nonreducing End Structures of Chondroitin Sulfate Chains on Aggrecan Isolated from Swarm Rat Chondrosarcoma Cultures (*) , 1995, The Journal of Biological Chemistry.
[28] D. Spillmann,et al. Defining the Interleukin-8-binding Domain of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.
[29] Catherine E Costello,et al. Improved hydrophilic interaction chromatography LC/MS of heparinoids using a chip with postcolumn makeup flow. , 2010, Analytical chemistry.
[30] L. Kjellén,et al. Regulated Diversity of Heparan Sulfate* , 1998, The Journal of Biological Chemistry.
[31] Joseph Zaia,et al. Organ-specific Heparan Sulfate Structural Phenotypes* , 2009, Journal of Biological Chemistry.
[32] M. Pardue,et al. The Journal of Cell Biology , 2002 .
[33] M. Lyon,et al. Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. , 1994, The Journal of biological chemistry.
[34] G. Giménez-Gallego,et al. Sequence Analysis of Heparan Sulfate Epitopes with Graded Affinities for Fibroblast Growth Factors 1 and 2* , 2001, The Journal of Biological Chemistry.
[35] M. Mohammadi,et al. A protein canyon in the FGF-FGF receptor dimer selects from an à la carte menu of heparan sulfate motifs. , 2005, Current opinion in structural biology.
[36] B. Olwin,et al. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation , 1991, Science.
[37] R. Langer,et al. Enzymatic degradation of glycosaminoglycans. , 1995, Critical reviews in biochemistry and molecular biology.
[38] Christopher J. Robinson,et al. VEGF165-binding Sites within Heparan Sulfate Encompass Two Highly Sulfated Domains and Can Be Liberated by K5 Lyase* , 2006, Journal of Biological Chemistry.
[39] L. Kjellén,et al. Contribution of EXT1, EXT2, and EXTL3 to Heparan Sulfate Chain Elongation* , 2007, Journal of Biological Chemistry.
[40] J. Platt,et al. In Vivo and in Vitro Degradation of Heparan Sulfate (HS) Proteoglycans by HPR1 in Pancreatic Adenocarcinomas , 2007, Journal of Biological Chemistry.
[41] Johan Ledin,et al. Heparan Sulfate Structure in Mice with Genetically Modified Heparan Sulfate Production* , 2004, Journal of Biological Chemistry.
[42] M. Ishihara,et al. Structural features in heparin that interact with VEGF165 and modulate its biological activity. , 1999, Glycobiology.
[43] P. Rudland,et al. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. , 2002, The Biochemical journal.
[44] Christopher J. Robinson,et al. Evidence That Heparin Saccharides Promote FGF2 Mitogenesis through Two Distinct Mechanisms* , 2008, Journal of Biological Chemistry.
[45] Zhengliang L. Wu,et al. The Involvement of Heparan Sulfate (HS) in FGF1/HS/FGFR1 Signaling Complex* , 2003, The Journal of Biological Chemistry.